Nachrichten

Save the date for the DigiMed Bayern Symposium 2024 in collaboration with the Digital Health Summit in Munich!

Mark your calendar for the DigiMed Bayern Symposium taking place on 6 November 2024 at TranslaTUM Munich, the Central Institute for Translational Cancer Research of TUM, next to Klinikum rechts der Isar. This year's symposium focues on "Big data from patients – relevant to understand, prevent, and cure disease?" and will precede the Digital Health Summit, taking place on 6-8 November 2024.

Please visit the DigiMed Bayern Symposium 2024 website for news!

In 2024, the focus of the Symposium will be on “big” and high-dimensional health data in clinical research with impact on healthcare. We will have a special eye on the required collaborative and future-proof IT-infrastructure.

TheDigiMedBayern partners will present the progress of the diverse projects in translational and data-driven research on cardiovascular diseases. In addition, renowned external experts will provide insights and input in the in the field of digital medicine and health data - from Multi-Omics signatures and AI diagnostics to machine learning algorithm development and imaging data usage.

This event will be a great platform to learn, network and discuss with exciting speakers and participants about advances in data-driven medicine and its potentials for patients, science, the health system, the economy and for the society as a whole.

Already confirmed, renowned speakers will be:

And from DigiMed Bayern:

Check out the program focusing on Personalized Medicine, Big Data and Compute Infrastructure for Collaborative Data - it is continuously updated.

We are looking forward to welcoming you at our DigiMed Bayern Symposium 2024!

About DigiMed Bayern

The Bavarian flagship project DigiMed Bayern aimstopreventheart attacks and strokes and represents data-based personalized medicine - using the widespread disease atherosclerosis as an example. The flagship project, which has been funded by the Bavarian State Ministry of Health and Care with a total volume of 24.5 million euros since 2018, pursues as the so-called P4 medicine.Thegoalis a personalized (tailored), preventive (avoiding), predictive (predicting) and participatory (participating) medicine of the future.

More information at: www.digimed-bayern.de.